A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 85,671 shares of ABBV stock, worth $15 Million. This represents 2.78% of its overall portfolio holdings.

Number of Shares
85,671
Previous 85,260 0.48%
Holding current value
$15 Million
Previous $14.6 Million 15.69%
% of portfolio
2.78%
Previous 2.41%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $67,338 - $81,924
411 Added 0.48%
85,671 $16.9 Million
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $17,491 - $20,425
-113 Reduced 0.13%
85,260 $14.6 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $1,118 - $1,274
-7 Reduced 0.01%
85,373 $15.5 Million
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $6,880 - $7,748
-50 Reduced 0.06%
85,380 $13.2 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $60,954 - $75,854
-460 Reduced 0.54%
85,430 $11.5 Million
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $20,608 - $24,714
-149 Reduced 0.17%
85,890 $0
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $8,186 - $9,389
-61 Reduced 0.07%
86,039 $11.5 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $12,538 - $15,556
95 Added 0.11%
86,100 $14 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $9.24 Million - $11.7 Million
86,005 New
86,005 $11.6 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $8.31 Million - $9.43 Million
-78,088 Closed
0 $0
Q2 2021

Sep 09, 2021

BUY
$105.21 - $117.21 $3,471 - $3,867
33 Added 0.04%
78,088 $8.8 Million
Q1 2021

Sep 09, 2021

BUY
$102.3 - $112.62 $2,557 - $2,815
25 Added 0.03%
78,055 $8.45 Million
Q4 2020

Sep 09, 2021

BUY
$80.49 - $108.67 $52,318 - $70,635
650 Added 0.84%
78,030 $8.36 Million
Q3 2020

Sep 09, 2021

BUY
$85.91 - $100.83 $12,886 - $15,124
150 Added 0.19%
77,380 $6.78 Million
Q2 2020

Sep 09, 2021

BUY
$73.37 - $98.18 $95,527 - $127,830
1,302 Added 1.71%
77,230 $7.58 Million
Q1 2020

Sep 09, 2021

BUY
$64.5 - $97.79 $21,285 - $32,270
330 Added 0.44%
75,928 $5.79 Million
Q4 2019

Sep 09, 2021

BUY
$72.13 - $90.25 $5.45 Million - $6.82 Million
75,598 New
75,598 $6.69 Million
Q3 2019

Nov 20, 2019

SELL
$62.98 - $75.72 $60,523 - $72,766
-961 Reduced 1.26%
75,593 $5.72 Million
Q1 2019

May 16, 2019

SELL
$77.14 - $90.79 $11,571 - $13,618
-150 Reduced 0.2%
76,554 $6.17 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $6.02 Million - $7.42 Million
-77,304 Closed
0 $0
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $50,366 - $59,595
-561 Reduced 0.72%
77,304 $7.16 Million
Q1 2018

May 16, 2018

SELL
$92.01 - $123.21 $51,525 - $68,997
-560 Reduced 0.71%
77,865 $7.37 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $45,317 - $49,694
506 Added 0.65%
78,425 $7.58 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $11,595 - $14,810
166 Added 0.21%
77,919 $6.92 Million
Q2 2017

Aug 24, 2017

BUY
N/A
77,753
77,753 $5.64 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.